US Broker Ratings

HCA Healthcare, Inc. (HCA) Stock Analysis: Potential Upside and Strong Buy Ratings Signal Growth Potential

Investors with a keen eye on the healthcare sector might find HCA Healthcare, Inc. (NYSE: HCA) an attractive proposition. With a market capitalization of $110.44 billion,..

Nuvalent, Inc. (NUVL) Stock Analysis: Potential 51.88% Upside on Innovative Cancer Therapies

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company, is gaining attention from investors eager to capitalize on its promising pipeline of cancer therapies. With a market..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Exploring a 42% Potential Upside for Investors

IQVIA Holdings, Inc. (NYSE: IQV), a prominent player in the healthcare sector, is catching the attention of investors with a compelling growth narrative and substantial potential..

Qiagen N.V. (QGEN) Stock Analysis: Exploring a 38% Potential Upside for Investors

Qiagen N.V. (NYSE: QGEN), a prominent player in the healthcare sector, specifically in diagnostics and research, is currently capturing investor attention with its promising financial metrics..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 47.65% Upside Potential in the Biotech Sector

Investors eyeing opportunities in the healthcare sector may find TG Therapeutics, Inc. (NASDAQ: TGTX) an intriguing prospect. With a market capitalization of $4.81 billion, this biopharmaceutical..

The Ensign Group, Inc. (ENSG) Investor Outlook: Unpacking the 10.16% Potential Upside

The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the healthcare sector, specifically in the medical care facilities industry, offers a compelling investment case with..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating a 16.82% Potential Upside in the Medical Devices Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a key player in the medical devices industry, has captured investor attention with a market capitalization of $17.41 billion and..

Ionis Pharmaceuticals (IONS): Investor Outlook on a Biotech Innovator with 32% Upside Potential

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a pioneering biotech company based in Carlsbad, California, presents an intriguing investment opportunity for those looking to delve into the biotechnology..

Option Care Health, Inc. (OPCH) Stock Analysis: A 42% Upside Potential Amidst Strong Buy Ratings

Option Care Health, Inc. (NASDAQ: OPCH), a dominant player in the U.S. healthcare sector, is drawing significant investor attention with its robust service offerings in home..

Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 26% Potential Upside in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector might find Teleflex Incorporated (NYSE: TFX) an intriguing prospect, particularly given its potential upside of 26.38%. With a market..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Unpacking a 41.77% Potential Upside for Investors

Investors eyeing the healthcare sector may want to take a closer look at Axsome Therapeutics, Inc. (NASDAQ: AXSM), a burgeoning player in the biotechnology industry. With..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a Potential 52.90% Upside

Investors keen on the healthcare sector may find Merit Medical Systems, Inc. (NASDAQ: MMSI) an intriguing prospect. With a current market capitalization of $3.96 billion, the..

Waters Corporation (WAT) Investor Outlook: Analyzing the 33% Potential Upside Driven by Strong Analyst Ratings

Waters Corporation (NYSE: WAT) stands as a formidable player in the healthcare sector, particularly within the Diagnostics & Research industry. With a market cap of $29.33..

Viatris Inc. (VTRS) Stock Analysis: Navigating a Complex Healthcare Landscape with a 17% Potential Upside

Viatris Inc. (VTRS), a prominent player in the healthcare sector, is forging a path through the complex landscape of drug manufacturing with a focus on both..

AstraZeneca PLC (AZN) Stock Analysis: Evaluating Growth Potential Amid a 13.53% Upside

AstraZeneca PLC (NASDAQ: AZN), a leading player in the healthcare sector, is drawing investor attention with a market capitalization of $284.63 billion and a strong presence..

Alcon Inc. (ALC)

⚠️ No article content returned.

..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Healthcare Innovator with 20.62% Potential Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable force in the biotechnology sector, particularly within the healthcare industry. With its headquarters in Boston, Massachusetts, Vertex..

AptarGroup, Inc. (ATR) Stock Analysis: Capitalize on a 34.64% Potential Upside in the Growing Healthcare Sector

Investors seeking opportunities in the healthcare sector should closely examine AptarGroup, Inc. (NYSE: ATR), a leader in the design and manufacturing of drug delivery and consumer..

Revolution Medicines (RVMD) Stock Analysis: A Look at the 39.59% Potential Upside in Precision Oncology

Investors are turning their attention to Revolution Medicines, Inc. (NASDAQ: RVMD), a trailblazer in the healthcare sector, specifically within the biotechnology industry. With a market capitalization..

BeOne Medicines Ltd. (ONC) Stock Analysis: Biotechnology Innovator with a 49% Upside Potential

BeOne Medicines Ltd. (NASDAQ: ONC), a prominent player in the biotechnology sector, has caught the attention of investors with its substantial growth potential. Based in Basel,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds